Torley Helen
CIK 1528185
Transactions on file
108
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-04 | 2026-06-03 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 6,100 | $425.1K | +2.6% | open → |
| 2026-06-04 | 2026-06-03 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 2,000 | $137.5K | +4.0% | open → |
| 2026-06-04 | 2026-06-03 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 1,500 | $101.5K | +5.6% | open → |
| 2026-06-04 | 2026-06-03 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 400 | $26.5K | +7.7% | open → |
| 2026-06-04 | 2026-06-03 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 10,000 | $120.7K | +492.2% | open → |
| 2026-06-04 | 2026-06-02 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 3,400 | $226.9K | +7.1% | open → |
| 2026-06-04 | 2026-06-02 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 16,600 | $1.10M | +7.8% | open → |
| 2026-06-04 | 2026-06-02 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 20,000 | $241.4K | +492.2% | open → |
| 2026-06-04 | 2026-06-01 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 5,401 | $369.1K | +4.6% | open → |
| 2026-06-04 | 2026-06-01 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 12,989 | $875.6K | +6.0% | open → |
| 2026-06-04 | 2026-06-01 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 1,610 | $106.9K | +7.7% | open → |
| 2026-06-04 | 2026-06-01 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 20,000 | $241.4K | +492.2% | open → |
| 2026-05-13 | 2026-05-13 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 600 | $42.5K | +0.9% | open → |
| 2026-05-13 | 2026-05-13 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 3,950 | $275.7K | +2.4% | open → |
| 2026-05-13 | 2026-05-13 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 3,350 | $230.7K | +3.8% | open → |
| 2026-05-13 | 2026-05-13 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 2,100 | $143.0K | +5.0% | open → |
| 2026-05-13 | 2026-05-13 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 10,000 | $120.7K | +492.2% | open → |
| 2026-05-13 | 2026-05-12 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 2,800 | $204.7K | -2.2% | open → |
| 2026-05-13 | 2026-05-12 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 5,900 | $425.7K | -0.9% | open → |
| 2026-05-13 | 2026-05-12 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 9,802 | $699.6K | +0.2% | open → |
| 2026-05-13 | 2026-05-12 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 1,398 | $98.3K | +1.7% | open → |
| 2026-05-13 | 2026-05-12 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 100 | $6.8K | +5.4% | open → |
| 2026-05-13 | 2026-05-12 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 20,000 | $241.4K | +492.2% | open → |
| 2026-05-13 | 2026-05-11 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 6,700 | $444.4K | +7.8% | open → |
| 2026-05-13 | 2026-05-11 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 3,575 | $234.0K | +9.2% | open → |
| 2026-05-13 | 2026-05-11 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 9,725 | $628.5K | +10.6% | open → |
| 2026-05-13 | 2026-05-11 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 20,000 | $241.4K | +492.2% | open → |
| 2025-02-18 | 2025-02-16 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Tax | 38,668 | $2.25M | +22.6% | open → |
| 2025-02-18 | 2025-02-16 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 71,810 | $0.00 | — | open → |
| 2025-02-18 | 2025-02-15 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Tax | 7,098 | $413.7K | +22.6% | open → |
| 2025-02-18 | 2025-02-15 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 13,092 | $0.00 | — | open → |
| 2025-02-18 | 2025-02-16 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Tax | 9,087 | $529.7K | +22.6% | open → |
| 2025-02-18 | 2025-02-16 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 16,875 | $0.00 | — | open → |
| 2025-02-18 | 2025-02-16 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Tax | 11,313 | $659.4K | +22.6% | open → |
| 2025-02-18 | 2025-02-16 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 21,009 | $0.00 | — | open → |
| 2025-02-24 | 2025-02-23 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 22,436 | $0.00 | — | open → |
| 2025-02-24 | 2025-02-23 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Tax | 12,081 | $697.7K | +23.8% | open → |
| 2025-06-24 | 2025-06-23 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 20,000 | $1.05M | +36.0% | open → |
| 2025-06-24 | 2025-06-24 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 4,489 | $238.4K | +34.6% | open → |
| 2025-06-24 | 2025-06-24 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 20,000 | $162.2K | +781.4% | open → |
| 2025-06-24 | 2025-06-24 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 15,511 | $836.2K | +32.6% | open → |
| 2025-06-24 | 2025-06-23 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 20,000 | $162.2K | +781.4% | open → |
| 2025-06-24 | 2025-06-20 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 20,000 | $1.06M | +35.0% | open → |
| 2025-06-24 | 2025-06-20 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 20,000 | $162.2K | +781.4% | open → |
| 2026-02-24 | 2026-02-23 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Tax | 12,104 | $855.0K | +1.2% | open → |
| 2026-02-24 | 2026-02-23 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 22,436 | $0.00 | — | open → |
| 2026-02-24 | 2026-02-20 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Tax | 9,040 | $641.7K | +0.7% | open → |
| 2026-02-24 | 2026-02-20 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 16,757 | $0.00 | — | open → |
| 2025-10-03 | 2025-10-03 | HALO HALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO | Sale | 724 | $51.9K | -0.3% | open → |
| 2025-10-03 | 2025-10-03 | HALO HALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO | Sale | 2,707 | $191.1K | +1.3% | open → |
| 2025-10-03 | 2025-10-03 | HALO HALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO | Sale | 2,334 | $163.0K | +2.4% | open → |
| 2025-10-03 | 2025-10-03 | HALO HALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO | Sale | 14,235 | $974.7K | +4.4% | open → |
| 2025-10-03 | 2025-10-03 | HALO HALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO | Exer. | 20,000 | $162.2K | +781.4% | open → |
| 2025-10-03 | 2025-10-02 | HALO HALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO | Sale | 100 | $7.5K | -4.3% | open → |
| 2025-10-03 | 2025-10-02 | HALO HALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO | Sale | 700 | $51.3K | -2.4% | open → |
| 2025-10-03 | 2025-10-02 | HALO HALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO | Sale | 2,400 | $173.0K | -0.8% | open → |
| 2025-10-03 | 2025-10-02 | HALO HALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO | Sale | 10,200 | $727.0K | +0.3% | open → |
| 2025-10-03 | 2025-10-02 | HALO HALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO | Sale | 6,600 | $465.4K | +1.4% | open → |
| 2025-10-03 | 2025-10-02 | HALO HALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO | Exer. | 20,000 | $162.2K | +781.4% | open → |
| 2025-10-03 | 2025-10-01 | HALO HALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO | Sale | 8,295 | $627.9K | -5.6% | open → |
| 2025-10-03 | 2025-10-01 | HALO HALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO | Sale | 11,705 | $879.2K | -4.8% | open → |
| 2025-10-03 | 2025-10-01 | HALO HALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO | Exer. | 20,000 | $162.2K | +781.4% | open → |
| 2025-12-01 | 2025-12-01 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 261 | $18.7K | -0.2% | open → |
| 2025-12-01 | 2025-12-01 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 500 | $35.2K | +1.6% | open → |
| 2025-12-01 | 2025-12-01 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 5,402 | $375.1K | +2.9% | open → |
| 2025-12-01 | 2025-12-01 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 10,406 | $712.9K | +4.3% | open → |
| 2025-12-01 | 2025-12-01 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 16,569 | $134.4K | +781.4% | open → |
| 2025-12-01 | 2025-11-26 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Gift | 25,000 | $0.00 | — | open → |
| 2025-11-12 | 2025-11-12 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 498 | $35.7K | -0.3% | open → |
| 2025-11-12 | 2025-11-12 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 6,784 | $482.3K | +0.6% | open → |
| 2025-11-12 | 2025-11-12 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 12,718 | $893.0K | +1.8% | open → |
| 2025-11-12 | 2025-11-12 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 20,000 | $162.2K | +781.4% | open → |
| 2025-11-12 | 2025-11-11 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 11,500 | $801.9K | +2.5% | open → |
| 2025-11-12 | 2025-11-11 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 4,000 | $275.2K | +3.9% | open → |
| 2025-11-12 | 2025-11-11 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 4,500 | $305.5K | +5.3% | open → |
| 2025-11-12 | 2025-11-11 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 20,000 | $162.2K | +781.4% | open → |
| 2025-11-12 | 2025-11-10 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 100 | $6.9K | +3.1% | open → |
| 2025-11-12 | 2025-11-10 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 19,900 | $1.37M | +4.0% | open → |
| 2025-11-12 | 2025-11-10 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 20,000 | $162.2K | +781.4% | open → |
| 2025-07-10 | 2025-07-09 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 20,000 | $162.2K | +781.4% | open → |
| 2025-07-10 | 2025-07-09 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 19,792 | $1.12M | +26.7% | open → |
| 2025-07-10 | 2025-07-08 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 3,598 | $196.0K | +31.2% | open → |
| 2025-07-10 | 2025-07-08 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 16,402 | $914.2K | +28.2% | open → |
| 2025-07-10 | 2025-07-09 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 208 | $11.9K | +25.2% | open → |
| 2025-07-10 | 2025-07-08 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 20,000 | $162.2K | +781.4% | open → |
| 2025-07-10 | 2025-07-10 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 20,000 | $162.2K | +781.4% | open → |
| 2025-07-10 | 2025-07-10 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 4,254 | $241.4K | +26.0% | open → |
| 2025-07-10 | 2025-07-10 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 15,746 | $907.3K | +24.1% | open → |
| 2025-08-13 | 2025-08-11 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 18,717 | $1.18M | +13.4% | open → |
| 2025-08-13 | 2025-08-12 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 6,958 | $445.3K | +11.7% | open → |
| 2025-08-13 | 2025-08-11 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 20,000 | $162.2K | +781.4% | open → |
| 2025-08-13 | 2025-08-13 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 5,052 | $327.5K | +10.3% | open → |
| 2025-08-13 | 2025-08-13 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 20,000 | $162.2K | +781.4% | open → |
| 2025-08-13 | 2025-08-11 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 1,283 | $81.6K | +12.4% | open → |
| 2025-08-13 | 2025-08-12 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 20,000 | $162.2K | +781.4% | open → |
| 2025-08-13 | 2025-08-12 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 13,042 | $824.8K | +13.0% | open → |
| 2025-08-13 | 2025-08-13 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 14,948 | $958.9K | +11.4% | open → |
| 2025-09-04 | 2025-09-03 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 9,500 | $705.1K | -3.7% | open → |
| 2025-09-04 | 2025-09-04 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 7,800 | $579.8K | -3.8% | open → |
| 2025-09-04 | 2025-09-04 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 9,900 | $728.0K | -2.8% | open → |
